Tenecteplase in Wake-up Ischaemic Stroke Trial

NCT03181360 · clinicaltrials.gov ↗

PHASE3

Phase

UNKNOWN

Status

600

Enrollment

OTHER

Sponsor class

Conditions

Ischemic Stroke
Stroke, Acute

Interventions

DRUG: Tenecteplase
OTHER: Control

Sponsor

University Hospital of North Norway

Collaborators

[object Object]
[object Object]
[object Object]